BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 7084114)

  • 1. Influence of tetracaine on the structure and function of estrogen receptors.
    Kim UH; Van Oosbree TR; Mueller GC
    Endocrinology; 1982 Jul; 111(1):260-8. PubMed ID: 7084114
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Release of receptor-bound estradiol by heparin or dextran sulfate in combination with tetracaine.
    Van Oosbree TR; Kim UH; Mueller GC
    J Recept Res; 1983-1984; 3(6):727-43. PubMed ID: 6207294
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Unique molecular properties of a urea- and salt-stable DNA-binding estrogen receptor dimer covalently labeled with the antiestrogen [3H]desmethylnafoxidine aziridine. A comparison with the estrogen-receptor complex.
    Hutchens TW; McNaught RW; Yip TT; Suzuki T; Li CM; Besch PK
    Mol Endocrinol; 1990 Feb; 4(2):255-67. PubMed ID: 2330004
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interaction of the antiestrogen [3H]H1285 with the two forms of the molybdate-stabilized calf uterine estrogen receptor.
    Keene JL; Ruh MF; Ruh TS
    J Steroid Biochem; 1984 Dec; 21(6):625-31. PubMed ID: 6527530
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antagonism to estradiol in the mouse: reduced entry of receptors complexed with 4-hydroxytamoxifen into a Mg2+-soluble chromatin fraction.
    Pavlik EJ; van Nagell JR; Nelson K; Gallion H; Donaldson ES; Kenady DE; Baranowska-Kortylewicz J
    Endocrinology; 1986 May; 118(5):1924-34. PubMed ID: 2422013
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dissimilarities between the uterine estrogen receptor in cytosol of castrated and estradiol-treated rats.
    Faye JC; Fargin A; Bayard F
    Endocrinology; 1986 Jun; 118(6):2276-83. PubMed ID: 3698914
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of antibodies to estrogen receptor on the binding of 3H-labeled antiestrogens and androstanediol in the uterus.
    Garcia M; Greene G; Rochefort H; Jensen EV
    Endocrinology; 1982 Apr; 110(4):1355-61. PubMed ID: 7060530
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Conversion of estrogen receptor from a state with low affinity for estradiol into a state of higher affinity does not require 4S to 5S dimerization.
    Müller RE; Traish AM; Hirota T; Bercel E; Wotiz HH
    Endocrinology; 1985 Jan; 116(1):337-45. PubMed ID: 2981069
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Extensive in situ activation of nuclear estrogen receptors after exposure of murine uteri to [3H]estradiol or [3H]4-hydroxytamoxifen.
    Pavlik EJ; Nelson K; van Nagell JR; Donaldson ES; Walden ML; Gallion H; Kenady DE
    Endocrinology; 1987 Apr; 120(4):1608-14. PubMed ID: 3830064
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ketononestrol aziridine, an agonistic estrogen receptor affinity label: study of its bioactivity and estrogen receptor covalent labeling.
    Elliston JF; Zablocki JA; Katzenellenbogen BS; Katzenellenbogen JA
    Endocrinology; 1987 Aug; 121(2):667-76. PubMed ID: 3595536
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ligand-receptor dissociation: a potential mechanism for the attenuation of estrogen action in the juvenile rabbit uterus.
    Chilton BS; Williams ND; Cobb AD; Leavitt WW
    Endocrinology; 1987 Feb; 120(2):750-7. PubMed ID: 3803303
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biological activity and receptor binding of a strongly interacting estrogen in human breast cancer cells.
    Reiner GC; Katzenellenbogen BS; Bindal RD; Katzenellenbogen JA
    Cancer Res; 1984 Jun; 44(6):2302-8. PubMed ID: 6547074
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A modulator which converts activated estrogen receptor to a biologically inactive aggregated form.
    Nishizawa Y; Maeda Y; Noma K; Sato B; Matsumoto K; Yamamura Y
    Endocrinology; 1981 Nov; 109(5):1463-72. PubMed ID: 6795027
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Estrogen receptor in avian embryo and adult liver: estrogen receptor activation and dissociation kinetics of estradiol, ethynylestradiol, and moxestrol.
    De Boer W; Snippe L; Ab G; Gruber M
    Endocrinology; 1982 Apr; 110(4):1217-24. PubMed ID: 7060523
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Estriol and estradiol interactions with the estrogen receptor in vivo and in vitro.
    Müller RE; Beebe DM; Bercel E; Traish AM; Wotiz HH
    J Steroid Biochem; 1984 Apr; 20(4B):1039-46. PubMed ID: 6727349
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antiestrogen binding in antiestrogen growth-resistant estrogen-responsive clonal variants of MCF-7 human breast cancer cells.
    Miller MA; Lippman ME; Katzenellenbogen BS
    Cancer Res; 1984 Nov; 44(11):5038-45. PubMed ID: 6488162
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antagonistic effect of triphenylethylenic antiestrogens on the association of estrogen receptor to calmodulin.
    Bouhoute A; Leclercq G
    Biochem Biophys Res Commun; 1992 May; 184(3):1432-40. PubMed ID: 1590802
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interaction of estradiol and estriol with uterine estrogen receptor in vivo and in excised uteri or cell suspensions at 37 C: noncooperative estradiol binding and absence of estriol inhibition of estradiol-induced receptor activation and transformation.
    Müller RE; Traish AM; Wotiz HH
    Endocrinology; 1985 Nov; 117(5):1839-47. PubMed ID: 4042965
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Estrogen receptor in chicken oviduct: receptor dissociation kinetics and transformation.
    de Boer W; Ab G; Gruber M
    J Steroid Biochem; 1985 Jul; 23(1):9-18. PubMed ID: 4021495
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Heterogeneity of nuclear estrogen-binding sites in the rat uterus: a simple method for the quantitation of type I and type II sites by [3H]estradiol exchange.
    Markaverich BM; Williams M; Upchurch S; Clark JH
    Endocrinology; 1981 Jul; 109(1):62-9. PubMed ID: 7238414
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.